A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

The neurorehabilitation devices market is expected to grow from US$ 2.73 billion in 2023, with CAGR of 12.7% during 2023–2031 ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the spread of brain proteins believed to be responsible for Parkinson's ...

Sipping one type of java can lower your risk of Alzheimer's disease, related dementias and Parkinson's disease.

IIT Madras and CMC researchers develop portable robot Pluto for hand rehabilitation, offering affordable, adaptable therapy ...

Indian Institute of Technology Madras IIT Madras and Christian Medical College Vellore CMC Vellore researchers have developed ...

Researchers at the Indian Institute of Technology (IIT) Madras and Christian Medical College (CMC) Vellore have developed a cost-effective, plug-and-play robot designed to provide rehabilitation ...

The Indian Institute of Technology Madras and Christian Medical College Vellore have launched PLUTO, an innovative and cost-effective robot for rehabilitation therapy. The device promises advanced ...